ReLiver

​

Derived from an unlimited stem cell source, our cell therapy platform will ultimately transform the treatment of liver disease. We are initially targeting acute and acute-on-chronic liver failure, the most challenging conditions that currently rely on liver transplantation as the only line of treatment.

®

ReLiver™ has been designed to be:

• Used as an allogeneic cell therapy

• Implantable via minimally invasive surgery

• Fully functional upon implantation

• Easily removed without sequelae once the patient’s liver regenerates

• Does not require immunosuppression

• Can be cryopreserved for on-demand use